---
document_datetime: 2023-09-21 18:52:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aloxi-epar-all-authorised-presentations_en.pdf
document_name: aloxi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.847785
conversion_datetime: 2025-12-25 02:53:01.581858
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration   | Packaging            | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|------------------------|---------------------------|----------------------|---------------------------|----------------|
| EU/1/04/306/001 | Aloxi           | 250 µg     | Solution for injection | Intravenous use           | vial (glass)         | 5 ml                      | 1 vial         |
| EU/1/04/306/002 | Aloxi           | 500 µg     | Soft capsule           | Oral use                  | blister OPA/alu/ PVC |                           | 5 capsules     |
| EU/1/04/306/003 | Aloxi           | 500 µg     | Soft capsule           | Oral use                  | blister OPA/alu/ PVC |                           | 1 capsule      |